Global Prostate Cancer Therapeutic Market to 2020

Publisher Name :
Date: 11-May-2015
No. of pages: 76

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some hindrances as well such as the high cost of prostate cancer drugs, low success rate of clinical trials and side effects of treatments among others.

Global Prostate Cancer - Key Therapies Analysis: The global market for prostate cancer therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets. Chemotherapy was the second leading therapy for prostate cancer in 2014. However, growth in the targeted therapy is predicted to push chemotherapy back at the third position, while immunotherapy for prostate cancer stands at the last position in the prostate cancer therapeutics market.

Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing stiff competition from Xtandi drugs which is expected to replace Zytiga as the leading prostate cancer drugs. In prostate cancer drugs market, Leuplin and Zoladex stands at the third and fourth position in 2014. The market share of both Leuplin and Zoladex is likely to plunge during the forecasting period. Lupron is standing at the fifth position. Bayer's targeted therapy drugs Xofigo is also rapidly catching up the market due to advantages such as increase in the overall survival and progression free survival with benign side effects profile.

Global Prostate Cancer Therapeutics Market to 2020 is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market.  

The 4 Prostate Cancer Therapy Market covered in the report are as follows:


  • Hormonal Therapy

  • Chemotherapy

  • Immunotherapy

  • Targeted Therapy


The above 4 Therapy has been further analyzed in terms of drugs sales and forecast (2011 - 2020):

1. Global Prostate Cancer - Hormonal Therapy Drugs Market


  • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists - Zytiga, Gonax

  • Luteinizing Hormone-Releasing Hormone (LHRH) Analogs - Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Leuplin

  • Anti-Androgens - Casodex, Xtandi or MDV3100, Xtandi US or MDV3100


2. Global Prostate Cancer - Chemotherapy Drugs Market


  • Taxotere

  • Jevtana


3. Global Prostate Cancer - Immunotherapy Drugs Market


  • Provenge


4. Global Prostate Cancer - Targeted Therapy Drugs Market


  • Xofigo or Alpharadin


Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Global Prostate Cancer Therapeutic Market to 2020

Table of Contents

1. Executive Summary

2. Global Prostate Cancer Therapeutics Market

3. Global Prostate Cancer Incidence

4. Global Prostate Cancer Therapeutics Market Share & Forecast (2011 - 2020)
4.1 Global Prostate Cancer - Therapy Market Share
4.2 Global Prostate Cancer - Drugs Market Share

5. Global Prostate Cancer Therapy Market & Forecast (2011 - 2020)
5.1 Global Prostate Cancer Hormonal Therapy Market & Forecast
5.2 Global Prostate Cancer Chemotherapy Market & Forecast
5.3 Global Prostate Cancer Immunotherapy Market & Forecast
5.4 Global Prostate Cancer Targeted Therapy Market & Forecast

6. Global Prostate Cancer - Hormonal Therapy Drugs Sales & Forecast To 2020
6.1 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
6.1.1 Zytiga
6.1.2 Gonax/ Firmagon
6.2 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
6.2.1 Lupron
6.2.2 Zoladex
6.2.3 Decapeptyl
6.2.4 Eligard
6.2.5 Vantas
6.2.6 Leuplin
6.3 Anti-Androgens
6.3.1 Casodex
6.3.2 Xtandi or MDV3100
6.3.3 Xtandi US or MDV3100

7. Global Prostate Cancer - Chemotherapy Drugs Market
7.1 Taxotere
7.2 Jevtana

8. Global Prostate Cancer - Immunotherapy Drugs Market
8.1 Provenge

9. Global Prostate Cancer - Targeted Therapy Drugs Market
9.1 Xofigo or Alpharadin

10. Global Prostate Cancer Market - Driving Factors
10.1 Innovative Drugs Driving the Market
10.2 Advancement in Oncology Therapeutic Area
10.3 Developments in Genomics & Proteomics

11. Global Prostate Cancer Market - Challenges
11.1 High Cost of Prostate Cancer Drugs
11.2 Adverse Events of Treatment
11.3 Low Success Rate in Clinical Testing For Oncology Drugs

List of Figures

Figure 2-1: Global - Prostate Cancer Therapeutics Market (Million US$), 2010 - 2014
Figure 2-2: Global - Forecast for Prostate Cancer Therapeutics Market (Million US$), 2015 - 2020
Figure 3-1: Global - Prostate Cancer Incidence (Number), 2007 - 2014
Figure 3-2: Global - Forecast for Prostate Cancer Incidence (Number), 2015 - 2020
Figure 5-1: Global Prostate Cancer - Hormonal Therapy Market (Million US$), 2011 - 2014
Figure 5-2: Global Prostate Cancer - Forecast for Hormonal Therapy Market (Million US$), 2015 - 2020
Figure 5-3: Global Prostate Cancer - Chemotherapy Market (Million US$), 2011 - 2014
Figure 5-4: Global Prostate Cancer - Forecast for Chemotherapy Market (Million US$), 2015 - 2020
Figure 5-5: Global Prostate Cancer - Immunotherapy Market (Million US$), 2011 - 2014
Figure 5-6: Global Prostate Cancer - Forecast for Immunotherapy Market (Million US$), 2015 - 2020
Figure 5-7: Global Prostate Cancer - Targeted Therapy Market (Million US$), 2013 - 2014
Figure 5-8: Global Prostate Cancer - Forecast for Targeted Therapy Market (Million US$), 2015 - 2020
Figure 6-1: Global - Zytiga Drugs Sales (Million US$), 2011 - 2014
Figure 6-2: Global - Forecast for Zytiga Drugs Sales (Million US$), 2015 - 2020
Figure 6-3: Global - Gonax/ Firmagon Drugs Sales (Million US$), 2012 - 2014
Figure 6-4: Global - Forecast for Gonax Drugs Sales (Million US$), 2015 - 2020
Figure 6-5: Global - Lupron Drugs Sales (Million US$), 2009 - 2014
Figure 6-6: Global - Forecast for Lupron Drugs Sales (Million US$), 2015 - 2020
Figure 6-7: Global - Zoladex Drugs Sales (Million US$), 2009 - 2014
Figure 6-8: Global - Forecast for Zoladex Drugs Sales (Million US$), 2015 - 2020
Figure 6-9: Global - Decapeptyl Drugs Sales (Million US$), 2009 - 2014
Figure 6-10: Global - Forecast for Decapeptyl Drugs Sales (Million US$), 2015 - 2020
Figure 6-11: Global - Eligard Drugs Sales (Million US$), 2009 - 2014
Figure 6-12: Global - Forecast for Eligard Drugs Sales (Million US$), 2015 - 2020
Figure 6-13: Global - Vantas Drugs Sales (Million US$), 2009 - 2014
Figure 6-14: Global - Forecast for Vantas Drugs Sales (Million US$), 2015 - 2020
Figure 6-15: Global - Leuplin Drugs Sales (Million US$), 2009 - 2014
Figure 6-16: Global - Forecast for Leuplin Drugs Sales (Million US$), 2015 - 2020
Figure 6-17: Global - Casodex Drugs Sales (Million US$), 2009 - 2014
Figure 6-18: Global - Forecast for Casodex Drugs Sales (Million US$), 2015 - 2020
Figure 6-19: Global - Xtandi or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-20: Global - Forecast for Xtandi or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 6-21: Global - Xtandi US or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-22: Global - Forecast for Xtandi US or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 7-1: Global - Taxotere Drugs Sales (Million US$), 2011 - 2014
Figure 7-2: Global - Forecast for Taxotere Drugs Sales (Million US$), 2015 - 2020
Figure 7-3: Global - Jevtana Drugs Sales (Million US$), 2010 - 2014
Figure 7-4: Global - Forecast for Jevtana Drugs Sales (Million US$), 2015 - 2020
Figure 8-1: Global - Provenge Drugs Sales (Million US$), 2011 - 2014
Figure 8-2: Global - Forecast for Provenge Drugs Sales (Million US$), 2015 - 2020
Figure 9-1: Global - Xofigo or Alpharadin Drugs Sales (Million US$), 2013 - 2014
Figure 9-2: Global - Forecast for Xofigo or Alpharadin Drugs Sales (Million US$), 2015 - 2020
Figure 11-1: Therapeutic Categories - Overall Success Rate from Phase 1 through Likelihood of Approval (Percent), 2004 - 2010

List of Tables

Table 4-1: Global - Prostate Cancer Therapy Market Share (Percent), 2011 - 2014
Table 4-2: Global - Forecast for Prostate Cancer Therapy Market Share (Percent), 2015 - 2020
Table 4-3: Global - Prostate Cancer Drugs Market Share (Percent), 2011 - 2014
Table 4-4: Global - Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 - 2020

  • Global Circulating Tumor Cells Market Professional Survey Report 2018
    Published: 18-Apr-2018        Price: US 3500 Onwards        Pages: 110
    This report studies Circulating Tumor Cells in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Janssen - Qiagen(Adnagen) - Acousys Biodevices - ApoCell......
  • Global Melanoma Therapeutics Market Size, Status and Forecast 2025
    Published: 05-Apr-2018        Price: US 3300 Onwards        Pages: 98
    This report studies the global Melanoma Therapeutics market, analyzes and researches the Melanoma Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - AstraZeneca - Amgen, Inc. - F. Hoffmann-La Roche Ltd. - Bristol-Myers Squibb Company - Novartis AG - Merck & Co., Inc. - Daiichi Sankyo Company, Limited - AB Sciences ......
  • United States Circulating Tumor Cells Market Report 2018
    Published: 27-Mar-2018        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Circulating Tumor Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and......
  • Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2025
    Published: 22-Mar-2018        Price: US 3300 Onwards        Pages: 90
    This report studies the global Glioblastoma Multiforme Treatment market, analyzes and researches the Glioblastoma Multiforme Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - AbbVie, Inc - Activartis GmbH - Agenus Inc - Arog Pharmaceuticals, Inc - Bristol-Myers Squibb Company - Cavion LLC - Celldex Therapeutics Inc - Cortice......
  • Global Bladder Cancer Therapeutics Market Size, Status and Forecast 2025
    Published: 21-Mar-2018        Price: US 3300 Onwards        Pages: 97
    This report studies the global Bladder Cancer Therapeutics market, analyzes and researches the Bladder Cancer Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - F. Hoffman-La Roche - Eli Lilly - Bristol-Myers Squibb - Merck - Sanofi - AstraZeneca - Bedford Lab - Accord Healthcare Market segme......
  • Global Circulating Tumor Cells Market Research Report 2018
    Published: 16-Mar-2018        Price: US 2900 Onwards        Pages: 118
    In this report, the global Circulating Tumor Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Circulating Tumor Cells in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - Ch......
  • Global Circulating Tumor Cells Sales Market Report 2018
    Published: 14-Mar-2018        Price: US 4000 Onwards        Pages: 119
    In this report, the global Circulating Tumor Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Circulating Tumor Cells for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe......
  • Global Kaposi Sarcoma Market Size, Status and Forecast 2025
    Published: 07-Mar-2018        Price: US 3300 Onwards        Pages: 91
    This report studies the global Kaposi Sarcoma market, analyzes and researches the Kaposi Sarcoma development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Merck - Pfizer - Johnson & Johnson - GlaxoSmithKline - Bristol-Myers Squibb - Eli Lilly Market segment by Regions/Countries, this report covers - United States - EU - ......
  • Global Melanoma Partnering 2012 to 2018
    Published: 01-Mar-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Melanoma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understand......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs